PRDM10

PR/SET domain 10, the group of Zinc fingers C2H2-type|PR/SET domain family

Basic information

Region (hg38): 11:129899706-130002835

Links

ENSG00000170325NCBI:56980OMIM:618319HGNC:13995Uniprot:Q9NQV6AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Birt-Hogg-Dube syndrome 2 (Limited), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Birt-Hogg-Dube syndrome ADOncologicThe condtiion involve an increased risk of a variety of neoplasms, and awareness may allow early detection and management of oncologic sequelaeDermatologic; Oncologic36440963

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PRDM10 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRDM10 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
3
missense
40
clinvar
2
clinvar
2
clinvar
44
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 40 2 5

Variants in PRDM10

This is a list of pathogenic ClinVar variants found in the PRDM10 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-129902345-C-T not specified Uncertain significance (Aug 04, 2023)2602626
11-129902351-C-T not specified Uncertain significance (Dec 08, 2023)3218337
11-129902356-G-T not specified Uncertain significance (May 24, 2024)3309745
11-129902498-C-T not specified Uncertain significance (Nov 08, 2022)2324851
11-129902507-C-G not specified Uncertain significance (Aug 04, 2023)2602660
11-129905664-T-C not specified Uncertain significance (Jun 13, 2024)3309747
11-129905727-T-G not specified Uncertain significance (Mar 16, 2022)2278516
11-129910517-T-C not specified Uncertain significance (Aug 02, 2021)2240329
11-129910541-T-G Likely benign (Dec 01, 2022)2642544
11-129910559-A-G not specified Uncertain significance (Dec 17, 2021)2267954
11-129910599-A-T Benign (Jul 06, 2018)787917
11-129912108-C-G not specified Uncertain significance (Oct 13, 2023)3218336
11-129912108-C-T not specified Uncertain significance (May 12, 2024)2367351
11-129912185-A-G not specified Uncertain significance (Oct 17, 2023)3218334
11-129914744-T-C not specified Uncertain significance (Feb 15, 2023)2484136
11-129914772-C-T not specified Uncertain significance (Apr 04, 2023)2532665
11-129914888-C-T not specified Uncertain significance (Oct 04, 2022)2316105
11-129914980-C-G not specified Uncertain significance (Dec 21, 2023)3218333
11-129915688-G-A not specified Uncertain significance (Jan 17, 2024)3218332
11-129915730-G-A not specified Uncertain significance (Apr 28, 2022)2286603
11-129915775-C-T not specified Uncertain significance (Aug 02, 2021)2227251
11-129917224-G-A not specified Uncertain significance (Dec 04, 2023)3218331
11-129918598-C-T not specified Uncertain significance (Jan 17, 2024)3218329
11-129918648-C-T not specified Uncertain significance (Dec 21, 2022)2208590
11-129923264-C-T Uncertain significance (-)1209928

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PRDM10protein_codingprotein_codingENST00000358825 21103130
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.1530.8471257250231257480.0000915
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.284657110.6540.00004397621
Missense in Polyphen195362.290.538253716
Synonymous0.02542872880.9980.00001892235
Loss of Function5.611563.10.2380.00000354656

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001220.000122
Ashkenazi Jewish0.00009950.0000992
East Asian0.0001090.000109
Finnish0.0002310.000231
European (Non-Finnish)0.00008000.0000791
Middle Eastern0.0001090.000109
South Asian0.00006530.0000653
Other0.0001680.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: May be involved in transcriptional regulation. {ECO:0000250}.;

Intolerance Scores

loftool
0.185
rvis_EVS
-0.01
rvis_percentile_EVS
52.36

Haploinsufficiency Scores

pHI
0.341
hipred
Y
hipred_score
0.575
ghis
0.518

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.834

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Prdm10
Phenotype
growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
regulation of transcription by RNA polymerase II;regulation of gene expression;methylation
Cellular component
nucleus;histone methyltransferase complex
Molecular function
RNA polymerase II core promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;methyltransferase activity;metal ion binding